We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Siemens Healthineers

Provides customized electronic systems and advanced imaging, diagnostics, therapy, and healthcare IT solutions for th... read more Featured Products: More products

Download Mobile App




PET Software Enhances Diagnosis and Monitoring of Alzheimer's Disease

By MedImaging International staff writers
Posted on 31 Oct 2024
Print article
mage: syngo.PET Cortical Analysis software enables the measurement of beta-amyloid and tau protein deposits in the brain (Photo courtesy of Siemens Healthineers)
mage: syngo.PET Cortical Analysis software enables the measurement of beta-amyloid and tau protein deposits in the brain (Photo courtesy of Siemens Healthineers)

Alzheimer’s disease is marked by the buildup of beta-amyloid plaques and tau protein tangles in the brain. These deposits of beta-amyloid and tau appear in various brain regions at differing rates as the brain ages. Collectively, these pathological changes result in neurodegeneration, leading to cognitive and clinical deterioration in individuals affected by Alzheimer’s disease. The need for standardized measurements of beta-amyloid plaques via positron emission tomography (PET) has surged following the FDA's approval of new therapeutic drugs targeting Alzheimer's disease. These treatments aim to slow cognitive and functional decline in adults with mild cognitive impairment or mild dementia by eliminating beta-amyloid from the brain. Now, a software application with new features utilizes PET to measure these protein accumulations associated with Alzheimer's disease. Accurately quantifying the accumulation of amyloid plaques and tau proteins in the brains of Alzheimer’s patients can offer clinicians critical diagnostic and staging information pertaining to the disease.

Siemens Healthineers (Forchheim, Germany) has received CE Mark approval for two new features in its syngo.PET Cortical Analysis software. The first feature, Centiloid scoring, standardizes the measurement of brain amyloid plaques in PET scans across three commercially available beta-amyloid PET radiopharmaceuticals used in the diagnosis of Alzheimer’s disease. The second feature, tau PET quantification, evaluates and quantifies the distribution and density of tau protein tangles in the brain using images obtained with the radiopharmaceutical flortaucipir. The implementation of Centiloid scoring for beta-amyloid PET is significant for diagnosis, patient management, and the design of clinical trials focused on Alzheimer’s disease-modifying therapies. Siemens' new Centiloid scoring feature employs a 100-point scale to standardize beta-amyloid PET measurements, allowing clinicians to compare results across various PET scanners and tracers.

Moreover, tau deposits have been found to correlate closely with cognitive performance in individuals with Alzheimer’s disease. The new tau PET quantification feature from Siemens incorporates Braak staging, a six-stage model that classifies the progression of tau pathology in the brain and closely aligns with cognitive impairment levels, with advanced stages linked to more severe cognitive and clinical symptoms. Tau PET has played a vital role in recent amyloid-directed drug trials concerning patient stratification, drug management, and treatment response assessment. Given tau’s strong connection to disease severity, numerous investigational tau-targeted therapies are currently in different stages of clinical development, and tau PET quantification is expected to play a significant role in these trials.

“The addition of Centiloid scoring and tau PET quantification features to our syngo.PET Cortical Analysis software fortifies our integrated and comprehensive portfolio for detection, diagnosis, monitoring, and follow-up related to Alzheimer’s disease,” said Martin Cordell, PhD, director of product lifecycle management at Siemens Healthineers Molecular Imaging.

Related Links:
Siemens Healthineers

New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Digital X-Ray Detector Plate
Acuity DRe
Ultrasound Color LCD
U156W
Racks
Transducer Storage Racks and Stabilizers

Print article
Radcal

Channels

Radiography

view channel
Image: The CT scanner prototype eliminates the need for physical compression of the breast (Photo courtesy of Quion Lowe and Lisa Dahm/U of A Cancer Center)

Novel Breast Cancer Screening Technology Could Offer Superior Alternative to Mammogram

Breast cancer represents 15.5% of new cancer cases and 7% of cancer-related deaths in the United States. Approximately 13.1% of women will be diagnosed with breast cancer during their lifetime.... Read more

Ultrasound

view channel
Image: Wearable ultrasound device offers continuous, long-term monitoring of muscle activity (Photo courtesy of Muyang Lin/UC San Diego)

Wearable Ultrasound Device Provides Long-Term, Wireless Muscle Monitoring

Electromyography (EMG) is the current clinical standard for monitoring muscle activity, utilizing metal electrodes placed on the skin to capture electrical signals from muscles. Despite its long-standing... Read more

General/Advanced Imaging

view channel
Image: Heavy smokers can ben Image (2):	efit from lung cancer screening using low-dose CT (Photo courtesy of 123RF)

Low-Dose CT Screening for Lung Cancer Can Benefit Heavy Smokers

Lung cancer is often diagnosed at a late stage, with only about one-fifth to one-sixth of patients surviving five years after diagnosis. A new report now suggests that low-dose computed tomography (CT)... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The advocacy partnership aims to help accelerate access to life-saving treatments (Photo courtesy of Philips)

Philips and Medtronic Partner on Stroke Care

A stroke is typically an acute incident primarily caused by a blockage in a brain blood vessel, which disrupts the adequate blood supply to brain tissue and results in the permanent loss of brain cells.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.